These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4455328)

  • 1. Morphine analgesia and the bulbospinal noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics.
    Shiomi H; Takagi H
    Br J Pharmacol; 1974 Dec; 52(4):519-26. PubMed ID: 4455328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine analgesia and the bulbospinal serotonergic system: increase in concentration of 5-hydroxyindoleacetic acid in the rat spinal cord with analgesics.
    Shiomi H; Murakami H; Takagi H
    Eur J Pharmacol; 1978 Dec; 52(3-4):335-44. PubMed ID: 729643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain and the bulbospinal noradrenergic system: pain-induced increase in normetanephrine content in the spinal cord and its modification by morphine.
    Takagi H; Shiomi H; Kuraishi Y; Fukui K; Ueda H
    Eur J Pharmacol; 1979 Feb; 54(1-2):99-107. PubMed ID: 421747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: analgesia and increase in the normetanephrine level in the spinal cord.
    Kuraishi Y; Fukui K; Shiomi H; Akaike A; Takagi H
    Biochem Pharmacol; 1978; 27(23):2756-8. PubMed ID: 728230
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn. Systematic studies in sheep and an observation in a human.
    Bouaziz H; Tong C; Yoon Y; Hood DD; Eisenach JC
    Anesthesiology; 1996 Jan; 84(1):143-54. PubMed ID: 8572328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of morphine and narcotic antagonist analgesics on the spinal cord of acute and chronic spinal rats.
    Matsushita A; Takesue H; Kido R
    Jpn J Pharmacol; 1971 Feb; 21(1):134-6. PubMed ID: 5317246
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia.
    Zhong FX; Ji XQ; Tsou K
    Eur J Pharmacol; 1985 Oct; 116(3):327-30. PubMed ID: 2866969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
    Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
    Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions.
    Yoburn BC; Lutfy K; Sierra V; Tortella FC
    Eur J Pharmacol; 1990 Jan; 176(1):63-7. PubMed ID: 2311659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of raphe magnus and raphe pallidus lesions on morphine-induced analgesia and spinal cord monoamines.
    Proudfit HK
    Pharmacol Biochem Behav; 1980 Nov; 13(5):705-14. PubMed ID: 7443740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Sci Sin B; 1984 Feb; 27(2):169-77. PubMed ID: 6147015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions.
    Basbaum AI; Marley NJE; O'Keefe J; Clanton CH
    Pain; 1977 Feb; 3(1):43-56. PubMed ID: 876666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors.
    Kimura M; Obata H; Saito S
    Anesthesiology; 2014 Aug; 121(2):362-71. PubMed ID: 24887968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central noradrenergic mediation of nitrous oxide-induced analgesia in rats.
    Fukuhara N; Ishikawa T; Kinoshita H; Xiong L; Nakanishi O
    Can J Anaesth; 1998 Nov; 45(11):1123-9. PubMed ID: 10021965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action.
    Fukui K; Takagi H
    Br J Pharmacol; 1972 Jan; 44(1):45-51. PubMed ID: 5015040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesia, development of tolerance, and 5-hydroxytryptamine turnover in the rat after cerebral and systemic administration of morphine.
    Vasko MR; Vogt M
    Neuroscience; 1982 May; 7(5):1215-25. PubMed ID: 6180353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine induced alterations of gamma-aminobutyric acid and taurine contents and L-glutamate decarboxylase activity in rat spinal cord and thalamus: possible correlates with analgesic action of morphine.
    Kuriyama K; Yoneda Y
    Brain Res; 1978 Jun; 148(1):163-79. PubMed ID: 566149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. III - Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists.
    Ferreira SH; Nakamura M
    Prostaglandins; 1979 Aug; 18(2):201-8. PubMed ID: 523678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.